EFFICACY OF AN EARLY ADMINISTRATION OF L0013CP 10 MG/DAY VERSUS PLACEBO DURING 4 WEEKS IN THE TREATMENT OF INFECTIOUS DISEASES INDUCED ARTHRITIS PAINFUL SYMPTOMS. A MULTICENTER, RANDOMISED, DOUBLE BLIND, PLACEBO CONTROLLED CLINICAL TRIAL IN ADULT PATIENTS SUFFERING FROM CHIKUNGUNYA FEVER.

Trial Profile

EFFICACY OF AN EARLY ADMINISTRATION OF L0013CP 10 MG/DAY VERSUS PLACEBO DURING 4 WEEKS IN THE TREATMENT OF INFECTIOUS DISEASES INDUCED ARTHRITIS PAINFUL SYMPTOMS. A MULTICENTER, RANDOMISED, DOUBLE BLIND, PLACEBO CONTROLLED CLINICAL TRIAL IN ADULT PATIENTS SUFFERING FROM CHIKUNGUNYA FEVER.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 28 Jul 2012

At a glance

  • Drugs Mequitazine (Primary)
  • Indications Arthritis
  • Focus Therapeutic Use
  • Sponsors Pierre Fabre
  • Most Recent Events

    • 22 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top